Dr. Agarwal’s Health Care Limited is set to launch its Initial Public Offering (IPO) with the following key details:
IPO Details:
- Issue Size: Approximately ₹3,027.26 crores, comprising a fresh issue of ₹300.00 crores and an offer for sale of up to 27,272,600 equity shares.
- Price Band: ₹382 to ₹402 per share.
- Subscription Dates: Opens on January 29, 2025, and closes on January 31, 2025.
- Listing Date: Expected on February 5, 2025, on BSE and NSE.
Grey Market Premium (GMP):
- As of January 24, 2025, the GMP is ₹164, indicating a potential listing gain of approximately 40% over the upper price band of ₹402.
Financial Highlights:
- Revenue: ₹837.94 crores for the nine months ending September 30, 2024.
- Profit After Tax (PAT): ₹39.56 crores for the same period.
Investment Considerations:
- Retail Quota: 35% of the issue size.
- Minimum Application: 35 shares, totaling ₹14,070.
- Maximum Application: 13 lots (455 shares), totaling ₹182,550.
Conclusion:
Dr. Agarwal’s Health Care Limited’s IPO presents a significant opportunity in the healthcare sector, with a strong GMP indicating positive investor sentiment. Prospective investors should consider the company’s financial performance and the IPO details before making investment decisions.
